Page 5 - Saloni Goel

Tech blitz! Nifty IT logs best monthly gain in 6 years. Is the worst over?

The Nifty IT pack rebounded with an 18.4 per cent rise this month. Before this, Nifty IT's best show was in June 2020 when it rose 22.5 per cent.

Gold can hit $5500 by year-end; invest in a staggered manner: MOFSL

Even if silver performs, we believe the weightage for gold could be higher in one's portfolio, said Manav Modi of MOFSL.

Bajaj Finance jumps 6% to 52-week high after Q1 results; more upside ahead?

While brokerages called Bajaj Finance's Q1 performance spectacular, they remain dividend on the stock price performance amid valuation concerns.

Asian Paints sheds 3% despite bullish analyst views post Q1; here's why

Driven by price hikes of around 12 per cent during the quarter, Asian Paints posted a 40 per cent Y-o-Y growth in its net profit to ₹1,539 crore.

Indo-MIM shares list at 45% premium, beat expectations; how to trade now?

The debut was ahead of grey market expectations. Before the listing, Indo-MIM IPO's GMP was ₹187 per share, or 38.56 per cent.

Pulse check: How healthy is Manipal's ₹9,275-cr IPO for your portfolio?

Manipal Health IPO GMP is ₹10, suggesting a listing gain of less than 2 per cent at current levels. That said, analysts find it a compelling long-term bet.

US Fed Policy Preview: Markets brace for Kevin Warsh's inflation message

Fed policy preview: The bigger risk for the market lies not in the rate decision itself but in the possibility of a more hawkish tone than markets currently anticipate.

Tata Chemicals falls 3% as Q1 PAT tanks 81%. Should you buy, sell or hold?

Tata Chemicals share price: Hurt by lower realisations, reduced other income, and lower JV income, Tata Chemicals reported an 81 per cent decline in consolidated net profit to Rs 60 crore.

Infosys, TCS, Coforge: Nifty IT pack jumps 2.5%. What's behind the gains?

The sharp gains in IT stocks today follow easing valuations, a decent Q1 show, and an improving outlook after a sharp selloff this year.

AI unwinding real? Analysts decode Indian market impact, sectoral winners

The correction in chip stocks and concerns surrounding the AI trade have the potential to revive FPIs ' enthusiasm for Indian stocks.

Dr Lal Path jumps 8% to 52-week high on Q1 beat; up to 25% upside on cards

Dr Lal PathLabs' share price jumped 8 per cent to a fresh 52-week high of ₹1,893.65 on the BSE today. The company has posted a better-than-expected Q1 show, prompting analysts to raise target prices.

IndiGo sheds 3% on ₹238-cr Q1 loss, but brokerages stay bullish; here's why

IndiGo share price: Despite of a headline miss in Q1 earnings, analysts believe that IndiGo's structural story remains intact, prompting them to retain their ratings on the stock.

Indo-MIM IPO: Why do analysts prefer it over Xtranet, Lohia & Cube? Decoded

As investors struggle to decide the best bet, analysts' consensus lies with ₹3,811-crore Indo MIM IPO as they find its global leadership position, robust financials and strong grey market positioning.

Dr Reddy's Labs shares tank 9% to 52-week low after Q1 show. Time to sell?

Brokerages largely remain bearish on Dr Reddy's Labs shares following the Q1 earnings show.

Should you bet on Xtranet Technologies' ₹167-crore IPO? What brokerages say

Xtranet Technologies IPO has received mixed reviews, with Swastika recommending applying with a medium-term view. SBI Securities has a 'neutral' call on the offer.

IndiGo Q1 Preview: Will fare hike help drive PAT amid fuel cost spike?

To mitigate the impact of higher aviation turbine fuel (ATF), IndiGo has raised airfares, but analysts believe it will not be enough to stem the Q1 profit fall.

SBI Funds joins AMC fray: Is it a better bet than HDFC AMC, ICICI Pru AMC?

SBI Funds Management is now listed on Dalal Street, giving investors a new AMC stock to consider. Analysts decode which AMC stock is better placed for investors - SBI Funds, ICICI Pru AMC or HDFC AMC

Bharat Coking Coal shares crash 8% as Coal India arm posts surprise Q1 loss

Bharat Coking Coal shares have lost 10.45 per cent on a year-to-date (YTD) basis as investors booked profit in the counter following a massive upside over the IPO price of Rs 23.

Paytm reverses gain, falls 3% after Q1 show; board shelves bonus issue plan

Paytm shares declined 3 per cent in intraday trade as investors assessed the company's strong Q1 show and the board's plan to not proceed with the bonus issue announcement.

Rupee's depreciation pace, not level key for markets, shows 18-year history

For the world's third-largest oil importer and consumer, India, a falling rupee presents unique challenges: a weaker economy, wary foreign investors, and declining earnings quality.